Foundation for Research Support of the State of São Paulo Report issue

Foundation

Organization Overview

First Clinical Trial
2017
NCT03327116
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

FUNADERSP (Foundation for Research Support of the State of São Paulo)

Active Ingredients

Drugs in Other Trials (1)

methotrexate (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1